Geode Capital Management’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.5M | Buy |
971,927
+18,801
| +2% | +$416K | ﹤0.01% | 2033 |
|
|
2025
Q4 | $23.1M | Buy |
953,126
+788
| +0.1% | +$20.6K | ﹤0.01% | 1926 |
|
|
2025
Q3 | $24.3M | Buy |
952,338
+31,233
| +3% | +$741K | ﹤0.01% | 1899 |
|
|
2025
Q2 | $19.8M | Buy |
921,105
+33,849
| +4% | +$763K | ﹤0.01% | 1964 |
|
|
2025
Q1 | $20.3M | Buy |
887,256
+53,822
| +6% | +$1.42M | ﹤0.01% | 1891 |
|
|
2024
Q4 | $21.6M | Sell |
833,434
-9,337
| -1% | -$232K | ﹤0.01% | 1930 |
|
|
2024
Q3 | $21.1M | Buy |
842,771
+18,473
| +2% | +$436K | ﹤0.01% | 1950 |
|
|
2024
Q2 | $17.7M | Buy |
824,298
+36,108
| +5% | +$701K | ﹤0.01% | 2001 |
|
|
2024
Q1 | $14.6M | Buy |
788,190
+31,022
| +4% | +$542K | ﹤0.01% | 2101 |
|
|
2023
Q4 | $12.3M | Buy |
757,168
+35,722
| +5% | +$456K | ﹤0.01% | 2219 |
|
|
2023
Q3 | $9.96M | Buy |
721,446
+21,115
| +3% | +$333K | ﹤0.01% | 2272 |
|
|
2023
Q2 | $15.5M | Buy |
700,331
+35,015
| +5% | +$737K | ﹤0.01% | 2029 |
|
|
2023
Q1 | $14.5M | Buy |
665,316
+17,849
| +3% | +$401K | ﹤0.01% | 2013 |
|
|
2022
Q4 | $11.8M | Buy |
647,467
+27,296
| +4% | +$564K | ﹤0.01% | 2142 |
|
|
2022
Q3 | $14.1M | Buy |
620,171
+35,988
| +6% | +$770K | ﹤0.01% | 1995 |
|
|
2022
Q2 | $8.07M | Buy |
584,183
+218,956
| +60% | +$3.21M | ﹤0.01% | 2406 |
|
|
2022
Q1 | $8.3M | Sell |
365,227
-8,261
| -2% | -$217K | ﹤0.01% | 2470 |
|
|
2021
Q4 | $13.9M | Sell |
373,488
-92,239
| -20% | -$3.96M | ﹤0.01% | 2214 |
|
|
2021
Q3 | $19.7M | Sell |
465,727
-22,279
| -5% | -$1.07M | ﹤0.01% | 1968 |
|
|
2021
Q2 | $21.7M | Buy |
488,006
+133,124
| +38% | +$4.69M | ﹤0.01% | 1906 |
|
|
2021
Q1 | $12.8M | Buy |
354,882
+29,515
| +9% | +$1.17M | ﹤0.01% | 2186 |
|
|
2020
Q4 | $13M | Buy |
325,367
+35,243
| +12% | +$1.2M | ﹤0.01% | 1984 |
|
|
2020
Q3 | $8.4M | Buy |
290,124
+138,993
| +92% | +$3M | ﹤0.01% | 2059 |
|
|
2020
Q2 | $2.47M | Sell |
151,131
-1,583
| -1% | -$21.8K | ﹤0.01% | 2728 |
|
|
2020
Q1 | $1.45M | Buy |
152,714
+12,310
| +9% | +$169K | ﹤0.01% | 2843 |
|
|
2019
Q4 | $2.27M | Buy |
140,404
+4,922
| +4% | +$80K | ﹤0.01% | 2932 |
|
|
2019
Q3 | $2.25M | Buy |
135,482
+2,138
| +2% | +$40.1K | ﹤0.01% | 2875 |
|
|
2019
Q2 | $2.26M | Buy |
133,344
+33,395
| +33% | +$582K | ﹤0.01% | 2874 |
|
|
2019
Q1 | $1.79M | Buy |
99,949
+16,361
| +20% | +$260K | ﹤0.01% | 2918 |
|
|
2018
Q4 | $1M | Buy |
83,588
+21,267
| +34% | +$254K | ﹤0.01% | 3112 |
|
|
2018
Q3 | $1.09M | Buy |
62,321
+9,513
| +18% | +$188K | ﹤0.01% | 3185 |
|
|
2018
Q2 | $602K | Sell |
52,808
-16,576
| -24% | -$151K | ﹤0.01% | 3372 |
|
|
2018
Q1 | $354K | Hold |
69,384
| – | – | ﹤0.01% | 3517 |
|
|
2017
Q4 | $416K | Hold |
69,384
| – | – | ﹤0.01% | 3429 |
|
|
2017
Q3 | $396K | Hold |
69,384
| – | – | ﹤0.01% | 3440 |
|
|
2017
Q2 | $165K | Hold |
69,384
| – | – | ﹤0.01% | 3741 |
|
|
2017
Q1 | $145K | Hold |
69,384
| – | – | ﹤0.01% | 3743 |
|
|
2016
Q4 | $112K | Hold |
69,384
| – | – | ﹤0.01% | 3768 |
|
|
2016
Q3 | $127K | Buy |
+69,384
| New | +$132K | ﹤0.01% | 3743 |
|
Other funds holding BLFS
CC
VCM
FAM
Geode Capital Management's BLFS Position: Q1 2026 in Review
Geode Capital Management increased its BioLife Solutions (BLFS) stake by 2% in Q1 2026, buying an estimated $416K and bringing the position to 971,927 shares worth $18.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.
Geode Capital Management first reported a position in BLFS in Q3 2016 and has held it in 39 quarters since. The position peaked at $24.3M in Q3 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.
- Geode Capital Management held 971,927 shares of BioLife Solutions worth $18.5M as of Q1 2026.
- Geode Capital Management bought 18,801 BioLife Solutions shares in Q1 2026, an estimated $416K.
- BioLife Solutions made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2033 holding.
- Geode Capital Management first reported a position in BioLife Solutions in Q3 2016 and has held it in 39 quarters since.
- Geode Capital Management's BioLife Solutions position peaked at $24.3M in Q3 2025.
- 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.